|
Catalog Number
|
GTX110516
(
1
)
|
|
Product Name
|
TACC2 antibody
|
| Applications | IHC-P, WB |
| Application Note |
| Suggested dilution | Reference |
| IHC (Formalin-fixed paraffin-embedded sections) | 1:100-1:1000* |
Y |
| Western blot | 1:500-1:3000* |
|
Not tested in other applications.
*Optimal dilutions/concentrations should be determined by the researcher.
|
| Predicted Target Size | 309 kDa (note)
 (7)
|
| Positive Controls | 293T , A431 , H1299 , HeLa , HepG2 , Molt-4 , Raji |
| Form Supplied | Liquid |
| Concentration | 0.28
mg/ml
(Please refer to the vial label for the specific concentration) |
| Purification | Purified by antigen-affinity chromatography. |
| Full Name | transforming, acidic coiled-coil containing protein 2 |
| Product Description | Rabbit polyclonal antibody to TACC2 (transforming, acidic coiled-coil containing protein 2) |
| Background | Transforming acidic coiled-coil proteins are a conserved family of centrosome- and microtubule-interacting proteins that are implicated in cancer. This gene encodes a protein that concentrates at centrosomes throughout the cell cycle. This gene lies within a chromosomal region associated with tumorigenesis. Expression of this gene is induced by erythropoietin and is thought to affect the progression of breast tumors. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq] |
| Synonyms | AZU-1 antibody, ECTACC antibody, TACC2 antibody, anti zuai-1 antibody, transforming acidic coiled-coil-containing protein 2 antibody, "transforming, acidic coiled-coil containing protein 2 antibody" |
| Cellular Localization | Cytoplasm , Nucleus , Centrosome |
| Host | Rabbit |
| Clonality | Polyclonal |
| Target | TACC2 |
| Isotype | IgG |
| Immunogen | Carrier-protein conjugated synthetic peptide encompassing a sequence within the N-terminus region of human TACC2. The exact sequence is proprietary. |
| Antigen Species | Human |
| Species Reactivity | Human |
Predicted Cross Reactivity species  Predicted cross-reactivity:
Predicted cross-reactivity is based on sequence homology, with greater than 80% immunogen sequence identity considered positive.
Please note that we are only able to guarantee products to work in applications and species in which they have been tested.
| Mouse, Rat |
| Predict Reactivity Note | Mouse (100%), Rat (100%) |
| Conjugation | Unconjugated |